Compare OGI & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OGI | STXS |
|---|---|---|
| Founded | 2013 | 1990 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 215.8M | 210.0M |
| IPO Year | N/A | 2004 |
| Metric | OGI | STXS |
|---|---|---|
| Price | $1.65 | $2.41 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 525.2K | ★ 693.1K |
| Earning Date | 12-16-2025 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $164,107,753.00 | $30,075,000.00 |
| Revenue This Year | $59.31 | $24.48 |
| Revenue Next Year | $15.12 | $29.98 |
| P/E Ratio | $38.60 | ★ N/A |
| Revenue Growth | ★ 50.01 | 19.62 |
| 52 Week Low | $0.85 | $1.54 |
| 52 Week High | $2.08 | $3.59 |
| Indicator | OGI | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 52.83 | 44.47 |
| Support Level | $1.45 | $2.20 |
| Resistance Level | $1.72 | $2.46 |
| Average True Range (ATR) | 0.08 | 0.13 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 70.37 | 71.95 |
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.